Aveanna Healthcare Q2 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $471.90M Beat $457.58M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported Q2 adjusted losses of $(0.02) per share, beating the analyst consensus estimate of $(0.04) by 50%. This is a 166.67% decrease over earnings of $0.03 per share from the same period last year. The company also reported quarterly sales of $471.90 million, beating the analyst consensus estimate of $457.58 million by 3.13%. This is a 6.53% increase over sales of $442.95 million the same period last year.
August 10, 2023 | 10:32 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aveanna Healthcare's Q2 results beat analyst estimates, with a smaller loss and higher sales than expected. However, earnings decreased significantly compared to the same period last year.
Aveanna Healthcare's Q2 results exceeded analyst expectations, which could lead to a positive market reaction. However, the significant decrease in earnings compared to the same period last year could temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100